STEM-28. DOT1L EPIGENETICALLY REGULATES GBM BRAIN TUMOR STEM CELLS

The median survival for patients diagnosed with Glioblastoma (GBM) is only 14 months, due to recurrence, despite current treatment options of surgery, radio- and chemo- therapies. Recurrence results from the invasion of GBM cancer cells away from the initial cancerous mass and may be due to brain tu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Bozek, Danielle, Wang, Alice, Hao, Xiaoguang, Johnston, Michael, Luchman, H Artee, Weiss, Samuel
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692879/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.943
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki